Company Name : Sarabhai Chemicals Specialities
Address : Shantisadan, Mirzapur Road, Ahmedabad -38000
Tel No : 91 079 25507671
Email : info@sarabhaichemicals.com, oncology@sarabhai.co.in, infertility@sarabhai.co.in
Website : http://sarabhaichemicals.com/
Company Profile
Sarabhai Chemicals is one of the first integrated pharmaceutical Giants in India. It ranked among the top 10 healthcare companies. Pharmacy business of ASE Ltd was diversified into Sarabhai Chemicals, S G Pharmaceuticals, Sarabhai M Chemicals, Standard Chemicals and Synbiotics. Production of the group accounted for about 8% of total production of drugs & Pharmaceutical in India.
The journey of Sarabhai Chemicals in Oncology started since 1970 promoting Oncology Products of Bristol Mayer Squibb first time in India like Hydrea (Hydroxyurea) useful in the treatment of CML.
In 1997, Sarabhai Chemicals tied up with Chiron Biopharma of USA for their two biotech research products namely Proleukin (IL2) for MRCC & Cardioxane (Dexrazoxane) for Chemotherapy induced Cardio toxicity. These niche molecules were again first time in India launched by Sarabhai. Moreover Paxtal our own brand of Paclitaxel was also among the 1st few brands in India.
In late 2005, a Separate Oncology Division was carved & created to cover entire India. The Oncology Division thus enters with more baskets of products in the segment of Hematology, Solid Tumor & supportive segments.
Sarabhai Oncology currently covers 300 Medical Oncologists, 100 Hematologists and 300 Radiation Oncologists. Our products are approved in all the leading major Institution like Tata Hospital, Defense, Railways, and CGHS etc.
In 2012, Sarabhai Chemicals spreads it’s wings to fly for new destinations in different specialties like Infertility, Critical care and Dermatology & Cosmetology.
Today Sarabhai Chemicals is operating across the country with a trained field force of 50 people and planning to expand up to 200 by the end of this year 2013.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…